How Are Japan’s Regenerative Meds Regs Playing Out?

Nearly 18 months has passed since Japan formally adopted ground-breaking new and revised legislation governing the regulation of cell and tissue therapies in November 2014, but how is the new framework working out in practice?

More from Focus On Asia

More from Scrip